ENPP2 and cancer: Studies show that this might be caused by the overexpression of autotaxin (ATX), especially in aggressive cancers, which leads to decreasing levels of LPCs in plasma and increasing lysophosphatidic acid (LPA) in the tumor microenvironment [37,38].